Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 1038 Indian stocks· EOD 2026-09-25

Omaxe Limited

OMAXENSEReal Estate
₹118.53
+0.86 (+0.73%)
Sell

Momentum (93/100) does the heavy lifting; financial trend (0/100) is the drag.

ExpensiveSolvency risk
The bottom line

Omaxe Limited earns a Sell from StocksWizard, with a blended score of 38/100. We put fair value near ₹192.75; at ₹118.53 that leaves roughly 63% upside, so the stock screens undervalued by 63%. The price is about 13% below its 52-week high of ₹136.38 and 85% above the low of ₹64.09. Financial health scores 0/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 4 of 10 investability checks, with durability 5, valuation 15 and momentum 93 on our 0–100 scales.

Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Our fair value
₹192.75up 62.62%
Undervalued by 63%
Price ₹118.53Range ₹64.52–₹208.17
Relative multipleslow confidence

With a 20% margin of safety, our buy-below price is ₹154.2. Low-confidence estimate — limited data.

1-year price

EOD · 2026-09-25
1D
up 0.73%
1W
up 1.04%
1M
up 4.54%
3M
up 46.60%
6M
up 74.69%
1Y
—

52-week range

-13.09% from the 52-week high.

Trend check
Above 50-DMA₹106Above 200-DMA₹85

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Sell38
F
Financial health 0/100
Altman Z -0.02 · Distress zone

Piotroski F-score 4/9 — quality of earnings & balance sheet.

Our scores

Durability5
Valuation15
Momentum93

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 4 of 10 checks
Each check screens one fundamentals, valuation or trend signal.
  • No data: ROE above 15%
  • No data: Low debt (D/E < 0.5)
  • Fail: Positive free cash flow
  • Fail: Revenue growth > 10%: -36%
  • No data: Earnings growing
  • Fail: Net margin ≥ 10%: -55.6%
  • Fail: Current ratio > 1.5: 0.97
  • Pass: Below our fair value
  • Pass: Margin of safety ≥ 20%
  • Pass: Above 200-day average
  • Pass: Above 50-day average
  • No data: Positive 1-year return
  • Fail: Altman Z in safe zone: Z -0.02
  • Fail: Piotroski ≥ 7: 4/9

Annual financials

Revenue · 2014
₹1,623 Cr
Net profit
₹79 Cr
Margin
5%
2011
2012
2013
2014
Revenue Net profitLatest revenue YoY -22%

Shareholding

  • Promoter77.2%
  • Institutions4.2%
  • Public & other18.6%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹1,424 Cr
P/E ratio
—
P/B ratio
—
EPS (TTM)
₹-38.1
ROE
—
Debt / Equity
—
Profit margin
-55.6%
Free cash flow
₹-79 Cr
52-week high
₹136.38
-13.09% from high
52-week low
₹64.09
Dividend yield
—
Beta
-0.06
SWOT snapshot

Bull case vs bear case

Bull case

Opportunities

  • Trades ~63% below our estimated fair value.

Bear case

Threats

  • Rich valuation versus sector peers.
  • Balance-sheet stress — Altman Z -0.02.

About Omaxe Limited

Omaxe Limited is an Indian real estate developer operating across residential, commercial, retail, and integrated township projects. Its portfolio encompasses group housing, SCOs, shopping malls, hotels, and office spaces. The company changed its name from Omaxe Construction Limited in June 2006.

Omaxe Limited — frequently asked questions

Is Omaxe Limited a buy, hold or sell?

StocksWizard currently rates Omaxe Limited (OMAXE) a Sell, based on a blended score of 38/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

What is Omaxe Limited's fair value?

Our blended DCF and relative-valuation model estimates Omaxe Limited's fair value at about ₹192.75, versus a current price of ₹118.53 — roughly 63% upside. On that basis the stock looks undervalued by 63%.

Is Omaxe Limited financially healthy?

Omaxe Limited scores 0/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9.

How has Omaxe Limited's share price performed?

Omaxe Limited is up 47% over three months, and last traded at ₹118.53. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.